Common Adverse Events Associated with the Use of Ribavirin for Severe Acute Respiratory Syndrome in Canada

Abstract Although information on efficacy and adverse drug reactions is lacking, ribavirin has been used empirically for the treatment of severe acute respiratory syndrome (SARS). We report common adverse events in 110 patients with suspected or probable SARS who were treated with ribavirin. Sixty-one percent of the patients had evidence of hemolytic anemia, and hypocalcemia and hypomagnesmia were reported in 58% and 46% of patients, respectively.

[1]  M. Chan-yeung,et al.  A cluster of cases of severe acute respiratory syndrome in Hong Kong. , 2003, The New England journal of medicine.

[2]  T. Wright,et al.  The safety and tolerability of daily infergen plus ribavirin in the treatment of naíïve chronic hepatitis C patients , 2003, Journal of viral hepatitis.

[3]  D. Dieterich,et al.  A preliminary study of erythropoietin for anemia associated with ribavirin and interferon-α , 2001, American Journal of Gastroenterology.

[4]  P. Glue,et al.  The clinical pharmacology of ribavirin. , 1999, Seminars in liver disease.

[5]  N. Schluger,et al.  Severe measles pneumonitis in adults: evaluation of clinical characteristics and therapy with intravenous ribavirin. , 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[6]  M. Lai,et al.  Meta‐analysis: ribavirin‐induced haemolytic anaemia in patients with chronic hepatitis C , 2002, Alimentary pharmacology & therapeutics.

[7]  J. McCormick,et al.  Lassa fever. Effective therapy with ribavirin. , 1986, The New England journal of medicine.

[8]  L. Poon,et al.  Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia : a prospective study , 2003 .

[9]  R. K. Robins,et al.  Broad-Spectrum Antiviral Activity of Virazole: 1-f8- D-Ribofuranosyl- 1,2,4-triazole- 3-carboxamide , 1972, Science.

[10]  A. Chutaputti.  Adverse effects and other safety aspects of the hepatitis C antivirals , 2000, Journal of gastroenterology and hepatology.

[11]  C. Broome,et al.  Use of Ribavirin in the Treatment of Respiratory Syncytial Virus Infection , 1993, Pediatrics.

[12]  A. Sangchan.  Interferon Alfa-2b Alone or in Combination with Ribavin as Intial Treatment for Chronic Hepatitis C , 1998 .

[13]  Elizabeth Rea,et al.  Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area. , 2003, JAMA.

[14]  William M. Lee,et al.  Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group. , 1998, The New England journal of medicine.

[15]  Y. Guan,et al.  The severe acute respiratory syndrome. , 2003, The New England journal of medicine.

[16]  J. Leduc,et al.  Prospective, double-blind, concurrent, placebo-controlled clinical trial of intravenous ribavirin therapy of hemorrhagic fever with renal syndrome. , 1991, The Journal of infectious diseases.

[17]  R. Mercier,et al.  Treatment of RSV Pneumonia in Adults — Evidence of Ribavirin Effectiveness? , 1999, The Annals of pharmacotherapy.